MINIject in Glaucoma Today

In the latest issue of Glaucoma Today, iSTAR Medical’s minimally-invasive glaucoma surgery (MIGS) device MINIjectTM features as the only therapy currently available that reestablishes the physiological drainage pathway through the supraciliary route.

CEO Michel Vanbrabant to present at OIS Glaucoma virtual 2021

iSTAR Medical was selected to present the latest data for MINIjectTM, its minimally-invasive glaucoma surgery (MIGS) device, at the OIS Glaucoma Innovation Showcase on 21st October 2021 at 1:20PM EDT.

MINIjectTM longer-term data at ESCRS

The latest results from the European STAR-II trial of MINIjectTM, iSTAR Medical’s minimally invasive glaucoma surgery device (MIGS), will be presented at the 39th edition of the European Society of Cataract and Refractive Surgeons (ESCRS) annual meeting. ESCRS is taking place between October 8 and 11 in Amsterdam, the Netherlands. Professor Julián García Feijoó, Universidad Complutense, […]

iSTAR Medical’s Supraciliary MIGS presented at IGC

MINIjectTM, iSTAR Medical’s minimally invasive glaucoma surgery (MIGS) device, will be presented as part of the “On the Cutting Edge” talks during the opening session at the prestigious, invitation-only Interventional Glaucoma Congress (IGC) meeting in Chicago from 7 to 11 October 2021. Dr Brian Flowers, who will present iSTAR Medical’s technology, specializes in glaucoma and […]

MINIject’s data presented at European Ophthalmology Futures Forum, Virtual 2021

iSTAR Medical was selected for a presentation at the virtual European Ophthalmology Futures Forum this Thursday 7 October, where CEO Michel Vanbrabant will present competitive strengths for iSTAR Medical’s revolutionary MIGS device MINIjectTM.